Patents by Inventor Monir EJEMEL

Monir EJEMEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic promoters for gene therapy and protein expression
    Patent number: 12680111
    Abstract: The invention provides synthetic promoters and methods of using the same.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: July 14, 2026
    Assignee: University of Massachusetts
    Inventors: Yang Wang, Mark S. Klempner, Monir Ejemel, Qi Li, Zuoshang Xu
  • SYNTHETIC PROMOTERS FOR GENE THERAPY AND PROTEIN EXPRESSION
    Publication number: 20240043872
    Abstract: The invention provides synthetic promoters and methods of using the same.
    Type: Application
    Filed: March 11, 2022
    Publication date: February 8, 2024
    Inventors: Yang WANG, Mark S. KLEMPNER, Monir EJEMEL, Qi LI, Zuoshang XU
  • ANTI-SARS-COV-2 SPIKE PROTEIN ANTIBODIES AND METHODS OF USE
    Publication number: 20230192820
    Abstract: The invention provides anti-SARS-CoV-2 spike (S) protein antibodies and methods of using the same.
    Type: Application
    Filed: May 5, 2021
    Publication date: June 22, 2023
    Inventors: Yang WANG, Mark S.J. KLEMPNER, Qi LI, Monir EJEMEL